CAPRELSA is a prescription medicine used to treat medullary thyroid cancer that cannot be removed by surgery or that
has spread to other parts of the body. It takes a long time to get rid of CAPRELSA from your body. If you have question, please e-mail Allevaire Indian Team or call Allevaire India on +91-9818274099 (Mr. Kamal Kaushal) for further details.
Caprelsa is a prescription medication used to treat patients with medullary thyroid cancer (MTC) that cannot be removed by surgery or that has spread to other parts of the body, and in which the tumors are growing or causing symptoms.
Caprelsa can cause a change in the electrical activity of your heart called QT prolongation, which can cause irregular heartbeats and that may lead to death. You should not take CAPRELSA if you have had a condition called long
QT syndrome since birth.
Caprelsa (Vandetanib) Tablets suppliers in India. Allevaire India New Delhi, INDIA.
Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specialized in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of latest medicines that are available in countries of Europe and USA.
Alleviare Life Sciences connects the buyer with the supplier who can ship Caprelsa (Vandetanib) Tablets (Cancer Treatment Medicines) to any country of the world as per the buyer’s requirement and Government regulations of the country. Caprelsa (Vandetanib) Tablets is manufactured by AstraZeneca Pharmaceuticals LP.
Alleviare Life Sciences provides options for choosing exporter and supplier of Cancer treatment Medicines We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
The order for Caprelsa (Vandetanib) Tablets will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
CAPRELSA is a kinase inhibitor indicated for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease.
Limitation of Use:
Use CAPRELSA in patients with the indolent, asymptomatic or slowly progressing disease only after careful consideration of the treatment related risks of CAPRELSA.
Medicine Name: Caprelsa
Generic Name: Vandetanib
Approval Date: Feb 21, 2012
Available as (Form & Strength): 100 mg and 300mg tablets
Company Name: AstraZeneca Pharmaceuticals LP
Please contact +91 9818274099 for Caprelsa (Vandetanib) price in India
We take guarantee of quality and delivery anywhere in the world as per the buyerïs requirements.
Caprelsa is available.
Get In Touch
ALS helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Caprelsa (Vandetanib) Tablets on prescription and Import License in Patient’s Name only.
For foreign countries patients, Caprelsa (Vandetanib) Tablets can be made available in Send your inquiry to find Caprelsa (Vandetanib) Tablets in China, Cambodia, Indonesia the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For Caprelsa (Vandetanib) Tablets Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details